University of Minnesota Masonic Cancer Center Logo
Print this page.Mail this link to a friend.

Find a Clinical Trial


Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Kidney (Renal Cell) cancer Clinical Trials

Protocol Number Title
2001LS058
 MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2005LS023
 MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors
2005LS068
 Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies
2006CG060
 ECOG 2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
2007CG075
 COG AREN0532: Treatment for Very Low, Low, and Secondary Risk Favorable Histology Wilms Tumor.
2007NT091
 COG AREN03B2: Renal Tumors Classification, Biology and Banking Study.
2008CG157
 COG AREN0533 Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
2008IS063
 A Phase 1b Study of LY573636-Sodium in Combination with Sunitinib Malate in Patients with Metastatic Renal Cancer
2008IS066
 Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: Axis Trial
2008IS096
 VEG108844 A Study of Pazopanib Versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
2008LS035
 Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life
2008LS043
 Phase II Trial of Bortezomib and Rituximab for Patients with Post Transplant Lymphoproliferative Disorders (PTLD) MT2008-05R
2009CG014
 COG ADVL0821 A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, IND# 100947, NSC# 742460) in Children With Relapsed/Refractory Solid Tumors

13 trials displayed